Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
American Journal of Respiratory and Critical Care Medicine|June 26, 2020
The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical TrialMeiLan K Han, Gerard J Criner, Mark T Dransfield, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohortRupert C M Jones, David Price, Dermot Ryan, et al.
Respiratory Research|April 29, 2021
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbationsDave Singh, Gerard J Criner, Mark T Dransfield, et al.
Thorax|August 22, 2024
Consensus palliative care referral criteria for people with chronic obstructive pulmonary diseaseJennifer Philip, Yuchieh Kathryn Chang, Anna Collins, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 13, 2022
Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary DiseaseJill A Ohar, Gary T Ferguson, Donald A Mahler, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2022
Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid DoseChristian Domingo, Jorge F Maspero, Mario Castro, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 2, 2022
Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT TrialAndrea Gabrio, Necdet B Gunsoy, Gianluca Baio, et al.
ERJ Open Research|March 15, 2021
Prognostic value of clinically important deterioration in COPD: IMPACT trial analysisMeiLan K Han, Gerard J Criner, Mark T Dransfield, et al.
Advances in Therapy|July 11, 2020
Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT StudyMaggie Tabberer, C Elaine Jones, Sally Kilbride, et al.
Respiratory Research|June 7, 2020
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trialNicola C Day, Subramanya Kumar, Gerard Criner, et al.
Pageof 15